[1P-0613] Development of a novel peptide-based therapeutic agent against CML by targeting PH domain of p210 BCR-ABL.

〇MASAYA CHODA¹, MIHO TAKAHASHI¹, KENTARO SHIMASAKI³, NORIHITO SHIBATA², MIKIHIKO NAITO², KIYOTAKA NISHIKAWA¹ (1.Faculty of Life and Medical Sciences, Univ of Doshisha, 2.Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3.Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases)

chronic myeloid leukemia, PH domain, cardiolipin, mitophagy, peptide-based agent